Gamma-aminobutyric acid type A receptor alpha-2 beta-3 gamma-2 subtype (GABA-A receptor alpha2beta3gamma2)

The GABA-A receptor alpha-2 beta-3 gamma-2 subtype is a pentameric ligand-gated ion channel that serves as a primary mediator of inhibitory neurotransmission in the mammalian central nervous system [1, 3]. It is composed of two alpha-2, two beta-3, and one gamma-2 subunit, forming a central pore selective for chloride and bicarbonate ions [1, 8]. Upon binding of the endogenous neurotransmitter gamma-aminobutyric acid (GABA), the channel opens, leading to neuronal hyperpolarization and reduced excitability [8, 10]. This specific subtype is highly expressed in brain regions such as the hippocampus, amygdala, and cerebral cortex, where it plays a critical role in regulating emotional states and cognitive functions [2, 6]. Pharmacologically, the alpha-2 beta-3 gamma-2 subtype is a major target for benzodiazepines, which act as positive allosteric modulators to enhance GABAergic inhibition [7, 11]. Research indicates that the alpha-2 subunit is specifically responsible for the anxiolytic and analgesic effects of these drugs, distinguishing it from the alpha-1 subunit which mediates sedation [5, 7]. Consequently, this receptor is a high-priority target for developing non-sedating anxiolytics and treatments for chronic pain [7]. Dysfunction of this receptor subtype is associated with various disorders, including generalized anxiety disorder, epilepsy, and schizophrenia [3, 10].

Other names

GABA(A) receptor alpha-2/beta-3/gamma-2GABAA receptor alpha2beta3gamma2Alpha2beta3gamma2 GABA-A receptorGABRA2-GABRB3-GABRG2 complex

Positive allosteric modulation of the chloride channel via the benzodiazepine binding site, direct agonism at the GABA binding site, and non-competitive channel blockade [3, 8, 11].